|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,244 GBX | +1.19% |
|
+1.37% | +15.51% |
| Jul. 17 | AstraZeneca's Capivasertib Gets UK Marketing Authorization for Advanced Breast Cancer Treatment | MT |
| Jul. 17 | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
BRUSSELS, Jan 4 (Reuters) - The European Commission is in discussions with Pfizer and BioNTech about the possibility of ordering more doses of their COVID-19 vaccine, in addition to the 300 million shots already covered under an existing contract, a spokesman said on Monday.
"The Commission is checking whether there is a way to add additional doses to those for which we already have a deal," the spokesman said. (Reporting by Francesco Guarascio @fraguarascio; Editing by Kirsten Donovan)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 124.1 USD | -0.87% | +5.63% | 47.96B | ||
| 86.47 USD | -0.40% | +6.36% | 20.95B | ||
| 30.03 USD | +1.80% | +5.93% | 167B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +15.51% | 243B | |
| +55.35% | 848B | |
| +31.64% | 627B | |
| -0.10% | 363B | |
| +15.47% | 318B | |
| +13.10% | 299B | |
| +16.72% | 225B | |
| +16.54% | 179B | |
| +4.31% | 167B | |
| +2.52% | 125B |
ASTRAZENECA PLC 
